This company has been acquired
Tabula Rasa HealthCare Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Tabula Rasa HealthCare's earnings have been declining at an average annual rate of -17.4%, while the Healthcare Services industry saw earnings growing at 1.8% annually. Revenues have been growing at an average rate of 7.8% per year.
Anahtar bilgiler
-17.4%
Kazanç büyüme oranı
-12.0%
EPS büyüme oranı
| Healthcare Services Sektör Büyümesi | 1.7% |
| Gelir büyüme oranı | 7.8% |
| Özkaynak getirisi | n/a |
| Net Marj | -18.1% |
| Son Kazanç Güncellemesi | 30 Jun 2023 |
Yakın geçmiş performans güncellemeleri
Recent updates
Continuing To Avoid Tabula Rasa HealthCare Inc.
May 19Does Tabula Rasa HealthCare (NASDAQ:TRHC) Have A Healthy Balance Sheet?
May 11
Is Tabula Rasa HealthCare (NASDAQ:TRHC) Using Too Much Debt?
Feb 09Calculating The Fair Value Of Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)
Jan 19Why Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Could Be Worth Watching
Dec 06Is Tabula Rasa HealthCare (NASDAQ:TRHC) A Risky Investment?
Nov 05Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) Intrinsic Value Is Potentially 84% Above Its Share Price
Jul 26Is Tabula Rasa HealthCare (NASDAQ:TRHC) Using Too Much Debt?
Jun 28We Discuss Why Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) CEO Compensation May Be Closely Reviewed
Jun 05Tabula Rasa HealthCare, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 07Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) Intrinsic Value Is Potentially 60% Above Its Share Price
Apr 02Tabula Rasa HealthCare (NASDAQ:TRHC) Is Carrying A Fair Bit Of Debt
Mar 12Update: Tabula Rasa HealthCare (NASDAQ:TRHC) Stock Gained 51% In The Last Three Years
Feb 19Gelir ve Gider Dağılımı
Tabula Rasa HealthCare nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 23 | 338 | -61 | 85 | 11 |
| 31 Mar 23 | 321 | -64 | 82 | 12 |
| 31 Dec 22 | 300 | -77 | 81 | 14 |
| 30 Sep 22 | 286 | -72 | 84 | 14 |
| 30 Jun 22 | 277 | -58 | 72 | 14 |
| 31 Mar 22 | 268 | -59 | 74 | 16 |
| 31 Dec 21 | 260 | -52 | 73 | 15 |
| 30 Sep 21 | 268 | -70 | 76 | 15 |
| 30 Jun 21 | 271 | -80 | 79 | 17 |
| 31 Mar 21 | 283 | -80 | 82 | 16 |
| 31 Dec 20 | 221 | -57 | 62 | 14 |
| 30 Sep 20 | 293 | -57 | 80 | 19 |
| 30 Jun 20 | 297 | -44 | 78 | 20 |
| 31 Mar 20 | 297 | -36 | 80 | 21 |
| 31 Dec 19 | 285 | -32 | 73 | 22 |
| 30 Sep 19 | 269 | -36 | 66 | 20 |
| 30 Jun 19 | 249 | -18 | 58 | 18 |
| 31 Mar 19 | 221 | -40 | 43 | 16 |
| 31 Dec 18 | 204 | -47 | 36 | 12 |
| 30 Sep 18 | 190 | -26 | 33 | 10 |
| 30 Jun 18 | 169 | -30 | 28 | 8 |
| 31 Mar 18 | 149 | -3 | 26 | 7 |
| 31 Dec 17 | 133 | 13 | 26 | 6 |
| 30 Sep 17 | 117 | -3 | 27 | 5 |
| 30 Jun 17 | 109 | -8 | 25 | 4 |
| 31 Mar 17 | 102 | -7 | 21 | 4 |
| 31 Dec 16 | 95 | -3 | 16 | 4 |
| 30 Sep 16 | 87 | 4 | 11 | 4 |
| 30 Jun 16 | 80 | -11 | 11 | 4 |
| 31 Mar 16 | 75 | -12 | 10 | 3 |
| 31 Dec 15 | 70 | -13 | 10 | 3 |
| 30 Sep 15 | 64 | -20 | 10 | 2 |
| 30 Jun 15 | 59 | -6 | 9 | 2 |
| 31 Mar 15 | 53 | -5 | 8 | 1 |
| 31 Dec 14 | 48 | -5 | 6 | 2 |
| 31 Dec 13 | 25 | -9 | 5 | 1 |
Kaliteli Kazançlar: TRHC is currently unprofitable.
Büyüyen Kar Marjı: TRHC is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: TRHC is unprofitable, and losses have increased over the past 5 years at a rate of 17.4% per year.
Büyüme Hızlandırma: Unable to compare TRHC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: TRHC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (41.2%).
Özkaynak Getirisi
Yüksek ROE: TRHC's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.